跳至主要内容
临床试验/NCT01535534
NCT01535534Unknown不适用

Evaluation of Mediators of Inflammation, Prognostic Markers and Genetic Polymorphisms in Patients With Sepsis

Universitätsmedizin Mannheim1 个研究点 分布在 1 个国家目标入组 250 人开始时间: 2012年1月最近更新:
适应症

试验速览

阶段
不适用
入组人数
250
试验地点
1

研究概览

简要总结

During the past years many investigators have focused on the immunological changes in sepsis disease, and great attention has been paid to the development of practicable means of immunomonitoring. Little is known about diagnostic and prognostic vascular biomarkers during the time course of patients with sepsis.

详细描述

Primary Outcome Measures:

New diagnostic and prognostic markers for septic patients

Estimated Enrollment: 300 patients Study Start Date: January 2012 Estimated Study Completion Date: open Estimated Primary Completion Date: open

Intervention Details:

Procedure: vein puncture comparison of different inflammatory markers in the blood of septic patients

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 90 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • SIRS-Criteria
  • Proven Infection
  • One sepsis-induced organ-failure
  • Adults < 18 years old

排除标准

  • Pregnancy
  • Blood donor in the last 3 month

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Dr. med. Ursula Hoffmann

Principal Investigator

Universitätsmedizin Mannheim

研究点 (1)

Loading locations...

相似试验